PAXIP1 and neoplasm: Notably, compared to the Control + Vector group, intravenous inoculation with LV-PAXIP1-AS1 + Vector cells led to a significant reduction in the number of visible tumours in the lungs, which correlated with a lower number of metastatic loci.